Coronavirus
Live tutoring platform Vedantu recently raised $100 million as part of its Series D financing round, valuing the Bengaluru-based edtech player at $600 million. CEO and co-founder Vamsi Krishna talks to Forbes India about how the company plans to use the funds, Covid-19 tailwinds and the intensifying competition in the sector
At the back of global isolation due to the Covid-19 pandemic, China's strained ties with the US and India have had greater global ramifications for its tech giants. Find out here
The vaccinated animals still had some virus in their noses but significantly less than unvaccinated animals did
The studies each aim to enroll 30,000 people and determine whether the vaccines are safe and effective
The National Institutes of Health and Moderna Inc. in the US has begun Phase 3 trials of its vaccine. 30,000 volunteers have signed up, making it the world's largest COVID-19 vaccine study. Watch this video to find out the progress of COVID-19 vaccine trials in India
Some experts say it is unlikely that the virus will strike the same person twice within a short time, and that it will take a slow toll after the initial exposure
Inter-ministerial consultations have begun for unlock 3, which is likely to be notified from August 1
India witnessed yet another highest ever single day spike with 49,931 new COVID-19 cases being recorded in the last 24 hours. The national tally has now climbed to 14,35,453. The death toll is at 32,771 and the number of recoveries currently stands at 9,17,567
A weighted lottery gives everyone a chance at a drug or vaccine in short supply. But some have a better shot than others
The country nears the 13-lakh case mark, as most of the cases are being reported in the southern states